← 產業報告目錄
Exosome Development and Manufacturing Services Market by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and By Scalability, Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-27頁數 180報告編號 INSIGHTACE-1a524fca15
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Exosome Development and Manufacturing Services Market by Types of Service(s) Offered (Isolated Exosomes stood at USD 17.2 Bn in 2023, and is poised to reach USD 62.8 Bn by 2031, recording a CAGR of 17.9% from 2024 through 2031.
At its core, Exosome Development and Manufacturing Services by Types of Service(s) Offered (Isolated Exosomes pertains to membrane-bound extracellular vesicles, are secreted into the extracellular environment by a wide variety of cell types. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
The market's upward path is propelled by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Exosome Development and Manufacturing Services Market Snapshot
Chapter 4. Global Exosome Development and Manufacturing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Types of Service(s) Offered Estimates & Trend Analysis
5.1. by Types of Service(s) Offered & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Types of Service(s) Offered:
5.2.1. Isolated Exosomes
5.2.2. Exosome Characterization
5.2.3. Purification
5.2.4. Chromatography
5.2.5. Engineering
5.2.6. Targeted Delivery
5.2.7. Diagnostic Biomarker
5.2.8. Quality Control
Chapter 6. Market Segmentation 2: by Scale of Operation Estimates & Trend Analysis
6.1. by Scale of Operation & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Scale of Operation:
6.2.1. Discovery / Research
6.2.2. Preclinical
6.2.3. Clinical
Chapter 7. Market Segmentation 3: by Scalability Estimates & Trend Analysis
7.1. by Scalability & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Scalability:
7.2.1. Small
7.2.2. Mid-Sized
7.2.3. large
Chapter 8. Exosome Development and Manufacturing Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Types of Service(s) Offered, 2023-2031
8.1.2. North America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2023-2031
8.1.3. North America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scalability, 2023-2031
8.1.4. North America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Types of Service(s) Offered, 2023-2031
8.2.2. Europe Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2023-2031
8.2.3. Europe Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scalability, 2023-2031
8.2.4. Europe Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Types of Service(s) Offered, 2023-2031
8.3.2. Asia Pacific Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2023-2031
8.3.3. Asia-Pacific Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scalability, 2023-2031
8.3.4. Asia Pacific Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Types of Service(s) Offered, 2023-2031
8.4.2. Latin America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2023-2031
8.4.3. Latin America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scalability, 2023-2031
8.4.4. Latin America Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Types of Service(s) Offered, 2023-2031
8.5.2. Middle East & Africa Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2023-2031
8.5.3. Middle East & Africa Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by Scalability, 2023-2031
8.5.4. Middle East & Africa Exosome Development and Manufacturing Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 101 Bio
9.2.2. 10x Genomics
9.2.3. Aegle Therapeutics
9.2.4. Aethlon Medical
9.2.5. AMSBIO
9.2.6. Anjarium Biosciences
9.2.7. Aruna Bio
9.2.8. Bio-Techne
9.2.9. Capricor Therapeutics
9.2.10. CD Bioparticles
9.2.11. Cell Guidance Systems
9.2.12. Cellular Biomedicine Group (CBMG)
9.2.13. Clara Biotech
9.2.14. Codiak BioSciences
9.2.15. Creative Biolabs
9.2.16. Creative Biostructure
9.2.17. Creative Bioarray
9.2.18. Creative Proteomics
9.2.19. Curexsys
9.2.20. Direct Biologics
9.2.21. EV Therapeutics
9.2.22. EVerZom
9.2.23. Evox Therapeutics
9.2.24. ExoCoBio
9.2.25. Exogenus Therapeutics
9.2.26. Exosome Diagnostics
9.2.27. Exosome Plus
9.2.28. Exosomics
9.2.29. Exopharm
9.2.30. Exosome Sciences
9.2.31. Exosome Diagnostics
9.2.32. Exosome Plus
9.2.33. Izon Science
9.2.34. Kimera Labs
9.2.35. Lonza
9.2.36. MDimune
9.2.37. Miltenyi Biotec
9.2.38. NanoView Biosciences
9.2.39. Norgen Biotek
9.2.40. NurExone Biologic
9.2.41. System Biosciences (SBI)
9.2.42. Takeda
9.2.43. Thermo Fisher Scientific
9.2.44. Vesigen Therapeutics
9.2.45. VivaZome Therapeutics
9.2.46. XOStem
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們